Novo Nordisk shares in hot water after disappointing trial
-
Investors who had hopes that *Novo Nordisk* (NVO) could succeed outside of
weight-loss drugs were disappointed on Friday, *July 31*.
The Danish drugmaker...
час назад










Комментариев нет:
Отправить комментарий